This inventor holds 15 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Pharmaceutical Formulations. Top assignee: Fujifilm Corporation. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kanagawa, JP (2013)
- Kanagawa-ken, JP (2014)
- Ashigarakami-gun, JP (2019 - 2023)
Company Filing History:
Years Active: 2013-2025
Areas of Expertise:
Title: The Innovative Mind of Mikinaga Mori: Advancements in Liposome Technology
Introduction
Mikinaga Mori, a prominent inventor based in Ashigarakami-gun, Japan, has made significant contributions to the field of biopharmaceuticals through his innovative work on liposome compositions and methodologies. With a remarkable portfolio of 13 patents, Mori's inventions are pushing the boundaries of cancer treatment and drug delivery systems.
Latest Patents
Mori’s latest patents focus on liposome compositions designed to improve drug delivery methods. One of his notable inventions is a liposome composition that includes a nucleic acid analog anticancer agent with an excellent leakage rate. This patented method outlines specific ratios of lysophospholipids and nucleic acid agents, enhancing the efficacy of drug release at a controlled rate of 2 to 10 mass%. Additionally, he developed another liposome composition aimed at long-term preservation and controlled release rates of drugs through hyper-osmotic conditions, allowing for effective treatment over extended periods.
Career Highlights
Mikinaga Mori works at Fujifilm Corporation, a renowned company in the field of advanced imaging and information technology. His role within the organization has allowed him to leverage his expertise in biopharmaceuticals, aligning with the company's goals to innovate and enhance therapeutic solutions.
Collaborations
Throughout his career, Mori has collaborated with notable colleagues, including Takeshi Matsumoto and Makoto Ono. These partnerships have fostered a collaborative environment that encourages the exchange of ideas, further driving innovation in liposome technology and its applications in medicine.
Conclusion
Mikinaga Mori's inventive prowess and commitment to advancing liposome technologies have positioned him as a leading figure in the pharmaceutical industry. His patents not only represent significant technical advancements but also hold promise for improving cancer therapies and enhancing patient care. As the field of biopharmaceuticals continues to evolve, Mori's contributions will undoubtedly play a crucial role in shaping the future of drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile